Founded in 2017, VEROVACCiNES is a biotechnology company focused on developing innovative subunit marker vaccines for animal health. Its proprietary technology enables the creation of cost-effective vaccines that reduce immunization effort and minimize the need for antibiotics. A key advancement of the platform is the ability to combine multiple antigens into a single vaccine without increasing production costs, allowing protection against multiple pathogens or variants simultaneously. With a pipeline of several vaccine programs—many already validated at proof-of-concept stage—the company is working on solutions for poultry, swine, and ruminants, aiming to improve animal health and efficiency in modern agriculture.